Nexium, Esomeprazole News

Main Category: GastroIntestinal / Gastroenterology Also Included In: Arthritis / Rheumatology Clinical Trials / Drug Trials AstraZeneca and POZEN Inc.

The latest issue of the Alimentary Pharmacology & Therapeutics compares standard- with double-dose proton pump inhibitors for the healing of severe erosive esophagitis.

POZEN Inc. , announced that the U.S. Food and Drug Administration has accepted the New Drug Application for VIMOVO .

BOSTON Drugs commonly used to treat heartburn and acid-reflux disease dona t interfere with drugs used to prevent clotting in patients with heart disease, according to a new study.

VIMOVO is a fixed-dose combination of enteric-coated naproxen, a pain-relieving non-steroidal anti-inflammatory drug and immediate release esomeprazole, a proton pump inhibitor , under investigation for the treatment of the signs and symptoms of osteoarthritis , rheumatoid arthritis and ankylosing spondylitis in patients who are at risk of ...

Prilosec, Nexium, Prevacid, Aciphex. These and a dozen more drugs known as proton pump inhibitors have quickly become superstars of Big Pharma.

Abstract Researchers find that treating 'silent' acid reflux has no effect on asthma.

What's the latest news in the medical journals this month? Find out what your doctor is reading.

Researchers in the latest American Journal of Gastroenterology find that eradicating Helicobacter pylori infection is necessary in patients using long-term esomeprazole for reflux esophagitis.

To the Editor: In their article on the use of esomeprazole in patients with poorly controlled asthma ,1 Mastronarde et al.

PUMP INHIBITORS that are used to treat acid reflux have been associated with an increased risk for pneumonia, according to a recent study.

Popular antacids known as proton pump inhibitors , or PPIs , may cause or aggravate the very acid-reflux symptoms they're used to treat, according to a new study.

After proton pump inhibitor therapy is withdrawn, patients may be likely to experience acid-related symptoms, according to a study published in the July issue of Gastroenterology .

Jun 30, 2009 - POZEN Inc. , today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for the marketing approval of VIMOVO , the combination of enteric coated naproxen and immediate release esomeprazole.

New Study Shows Nexium 40 Mg And 20 Mg Reduced Gastric And Duodenal Ulcers By 80 - 85% In Patients Taking Low-Dose Aspirin For CV Protection Esomeprazole significantly reduced the occurrence of gastric and duodenal ulcers and upper gastrointestinal symptoms in patients taking low-dose aspirin for risk reduction of adverse cardiovascular events[i], ...

Two studies from AstraZeneca show that symptomatic gastroesophageal reflux disease patients treated with NEXIUM 20 mg daily experienced greater relief from nighttime heartburn and GERD-related sleep disturbances compared with patients taking placebo over four weeks .

Heartburn is ailing the masses. By one estimate, 20 percent of the Western population experiences acid reflux at least once a week.

It's not until you read the Indian press that it dawns on you what a total disaster Ranbaxy is - and by extension its deal to supply AstraZeneca with a Nexium ingredient.

Minakem Group, through its holding company Minafin, has completed the acquisition of a multi-purpose APIs plant, formerly owned by AstraZeneca and has signed with the latter a long-term supply contract for Budesonide, Omeprazole and Esomeprazole.

A new study has added to the concern that commonly used proton-pump inhibitors may interfere with Plavix in people who have coronary artery disease.